Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Estee Lauder Gains, Imax Jumps, Denali Therapeutics Slides After Parkinson’s Drug Trial Failure...
Posted
May 22, 2026
Views
108
Likes
2
Comments
1
Engagement
May 22, 2026
108
2
1
2.78%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:33Now PlayingOn this episode of Stock Movers:
- Estee Lauder (EL) shares gain. The US beauty company and Spanish firm Puig confirmed talks about a potential business combination have ended. Analysts cite several reasons for the positive reaction to the termination of talks, including “aversion to large deals,” integration risk/potential dilution to shareholders, as well as distraction to core business and its Beauty Reimagined strategic plan. Some analysts see better M&A opportunities in fragrance, or in masstige/mass segments.
- Imax (IMAX) shares jump. The Wall Street Journal reported the large-screen theater company is exploring a sale and has approached entertainment companies as potential buyers. The sale process is in early stages and may not result in a deal, the report states, citing people familiar with the situation
- Denali Therapeutics (DNLI) shares slide. The drug developer said a mid-stage study of an experimental therapy for Parkinson’s disease, with partner Biogen, did not meet its primary or secondary endpoints.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Estee Lauder Gains, Imax Jumps, Denali Therapeutics Slides After Parkinson’s Drug Trial Failure
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
